Skip to main content
. 2020 Nov 10;5(4):201–207. doi: 10.1016/j.ncrna.2020.11.003

Fig. 4.

Fig. 4

A schema of the hypothesis. miR-7-5p suppressed the activity of OGT by binding to the 3-UTR site of OGT, inhibiting the O-GlcNAcylation of oncoproteins. It could also regulate glucose metabolism through Akt, c-Myc, ChREBP, NF-κB, and HIF-1. Consequently, miR-7-5p inhibits cancer metabolism and the growth of cancer cells.